RESVEGA, a Nutraceutical Omega-3/Resveratrol Supplementation, Reduces Angiogenesis in a Preclinical Mouse Model of Choroidal Neovascularization
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is an eye disease that is characterized by damage to the central part of the retina, the macula, and that affects millions of people worldwide. At an advanced stage, a blind spot grows in the center of vision, severely handicapping patients with this degenerative condition. Despite therapeutic advances thanks to the use of anti-VEGF, many resistance mechanisms have been found to accentuate the visual deficit. In the present study, we explored whether supplementation with Resvega®, a nutraceutical formulation composed of omega-3 fatty acids and resveratrol, a well-known polyphenol in grapes, was able to counteract laser-induced choroidal neovascularization (CNV) in mice. We highlight that Resvega® significantly reduced CNV in mice compared with supplementations containing omega-3 or resveratrol alone. Moreover, a proteomic approach confirmed that Resvega® could counteract the progression of AMD through a pleiotropic effect targeting key regulators of neoangiogenesis in retina cells in vivo. These events were associated with an accumulation of resveratrol metabolites within the retina. Therefore, a supplementation of omega-3/resveratrol could improve the management or slow the progression of AMD in patients with this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and similar effects have been demonstrated in mouse models [ 56 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611 · cited 1×
“Identification of enriched pathways and protein network analysis were performed with the Metascape online database [31] (http://metascape.”
MethodDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Plant Polyphenols as Dietary Antioxidants in Human Health and Disease
Pandey, K. B., & Rizvi, S. I. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.5.9498 · Cited by 3,942
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,717
Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Patel, K. R., Brown, V. A., Jones, D. J. L., Britton, R. G., Hemingway, D., Miller, A. S., West, K. P., Booth, T. D., Perloff, M., Crowell, J. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2027 · Cited by 624
Krzystolik, M. G. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.3.338 · Cited by 590 · cited 1×
“This model is usually used to provide preclinical evidence to support the clinical evaluation of anti-VEGF drugs for neovascular eye diseases such as AMD and to evaluate new therapies for these conditions [12,13].”
MethodClinical trials of resveratrol
Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., & Brown, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05853.x · Cited by 522
Spilsbury, K., Garrett, K. L., Shen, W.-Y., Constable, I. J., & Rakoczy, P. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64525-7 · Cited by 394
Chong, E. W.-T. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.6.826 · Cited by 279 · cited 1×
“Indeed, a meta-analysis suggested that ω-3 fatty acids (such as DHA), which are essential dietary compounds found in fish such as salmon or tuna, could reduce the risk of both early and late AMD [21].”
BackgroundBoocock, D. J., Patel, K. R., Faust, G. E. S., Normolle, D. P., Marczylo, T. H., Crowell, J. A., Brenner, D. E., Booth, T. D., Gescher, A., & Steward, W. P. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.10.017 · Cited by 200 · cited 1×
“For analysis of RSV metabolites, the presence of RSV aglycon and RSV metabolites was analyzed in retinas and posterior poles by LC-MS (Agilent Technologies, Les Ulis, France), as previously described [17,32].”
MethodIn vivo confocal imaging of the retina in animal models using scanning laser ophthalmoscopy
Seeliger, M. W., Beck, S. C., Pereyra-Muñoz, N., Dangel, S., Tsai, J.-Y., Luhmann, U. F. O., van de Pavert, S. A., Wijnholds, J., Samardzija, M., Wenzel, A., et al. (2005) · Vision Research · doi:10.1016/j.visres.2005.08.014 · Cited by 171 · cited 1×
“At days 14 and 21 after the laser impacts, the animals were subjected to retinal angiographies according to procedures previously published by our team [29,30].”
MethodSelf-citationAntiangiogenic mechanisms of diet-derived polyphenols
Cao, Y., Cao, R., & Bråkenhielm, E. (2002) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(02)00204-8 · Cited by 167
Aires, V., Limagne, E., Cotte, A. K., Latruffe, N., Ghiringhelli, F., & Delmas, D. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200766 · Cited by 158 · cited 3×
“However, these findings suggest that the metabolites of resveratrol could play a role in the biological effects observed, as previously demonstrated in the context of colon cancer or myopathy [17,18].”
BackgroundInfluentialSelf-citationA Mouse Model for Laser-induced Choroidal Neovascularization
Shah, R. S., Soetikno, B. T., Lajko, M., & Fawzi, A. A. (2015) · Journal of Visualized Experiments · doi:10.3791/53502 · Cited by 100 · cited 1×
“Thus, after validation by the ethics committee of the university, we used this “gold standard” preclinical method, which is very well codified and documented in the literature [14].”
MethodImmunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Ghiringhelli, F., Rébé, C., Hichami, A., & Delmas, D. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650048 · Cited by 90
Self-citationNew Highlights of Resveratrol: A Review of Properties against Ocular Diseases
Delmas, D., Cornebise, C., Courtaut, F., Xiao, J., & Aires, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031295 · Cited by 75 · cited 1×
“More recently, studies have shown that polyphenols could also prevent or improve vision in patients with ocular diseases and especially AMD [5].”
BackgroundSelf-citationReliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation
Poor, S. H., Qiu, Y., Fassbender, E. S., Shen, S., Woolfenden, A., Delpero, A., Kim, Y., Buchanan, N., Gebuhr, T. C., Hanks, S. M., et al. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15067 · Cited by 73 · cited 1×
“This model is usually used to provide preclinical evidence to support the clinical evaluation of anti-VEGF drugs for neovascular eye diseases such as AMD and to evaluate new therapies for these conditions [12,13].”
MethodRicher, S., Patel, S., Sockanathan, S., Ulanski, L., Miller, L., & Podella, C. (2014) · Nutrients · doi:10.3390/nu6104404 · Cited by 60
Richer, S., Stiles, W., Ulanski, L., Carroll, D., & Podella, C. (2013) · Nutrients · doi:10.3390/nu5061989 · Cited by 57 · cited 2×
“Another clinical trial performed in the USA in octogenarians also showed that oral administration of Longevinex®, which is a combination of RSV with quercetin, ferulic acid together with vitamin D3, and a cooper/iron/calcium binding molecule called IP6 (inositol hexaphosphate), could improve retinal structure and visu…”
BackgroundDevelopment of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians
Keane, P. A., & Sadda, S. R. (2012) · Journal of Ophthalmology · doi:10.1155/2012/483034 · Cited by 51 · cited 1×
“) [2], treatment failure still occurs due to side effects and resistance.”
BackgroundAires, V., Delmas, D., Bachelier, C. L., Latruffe, N., Schlemmer, D., Benoist, J., Djouadi, F., & Bastin, J. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-9-79 · Cited by 51
Self-citationNutraceutical with Resveratrol and Omega-3 Fatty Acids Induces Autophagy in ARPE-19 Cells
Koskela, A. K. J., Reinisalo, M., Petrovski, G., Sinha, D., Olmière, C., Karjalainen, R., & Kaarniranta, K. (2016) · Nutrients · doi:10.3390/nu8050284 · Cited by 44
Tissue Distribution oftrans-Resveratrol and Its Metabolites after Oral Administration in Human Eyes
Wang, S., Wang, Z., Yang, S., Yin, T., Zhang, Y., Qin, Y., Weinreb, R. N., & Sun, X. (2017) · Journal of Ophthalmology · doi:10.1155/2017/4052094 · Cited by 39
Lin, C.-T., Sun, X.-Y., & Lin, A.-X. (2016) · Renal Failure · doi:10.3109/0886022x.2015.1128236 · Cited by 38
Querques, G., Benlian, P., Chanu, B., Portal, C., COSCAS, G. J., Soubrane, G., & Souied, E. H. (2009) · European Journal of Ophthalmology · doi:10.1177/112067210901900115 · Cited by 37 · cited 8×
“Resvega ® (Laboratoires Th é a, Clermont-Ferrand, France) is a nutraceutical composed of vitamin C 240 mg; E 30 mg; zinc 12.5 mg; Cu 1 mg; EPA 380 mg; DHA 190 mg; lutein 10 mg; zeaxanthin 2 mg; trans -resveratrol 30 mg. Nutrof ® (NUT) (Laboratoires Th é a, Clermont-Ferrand, France) is a nutraceutical composed of vitam…”
BackgroundInfluentialA Mouse Model for Laser-induced Choroidal Neovascularization
Shah, R. S., Soetikno, B. T., Lajko, M., & Fawzi, A. A. (2015) · Journal of Visualized Experiments · doi:10.3791/53502-v · Cited by 32
Resvega Alleviates Hydroquinone-Induced Oxidative Stress in ARPE-19 Cells
Bhattarai, N., Korhonen, E., Toppila, M., Koskela, A. K. J., Kaarniranta, K., Mysore, Y., & Kauppinen, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062066 · Cited by 30 · cited 1×
“Other authors have also confirmed an interest in this formulation for various molecular processes such as inflammation [9], oxidative stress [10], and autophagy [11] in retinal cell models.”
BackgroundThierry, M., Pasquis, B., Acar, N., Gregoire, S., Febvret, V., Buteau, B., Gambert, S., Bron, A. M., Creuzot-Garcher, C. P., & Brétillon, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112450 · Cited by 24 · cited 2×
“Four argon laser impacts (300 Mw, diameter 75 μm for 50 ms, Vitra; Quantel Medical) were delivered on the fundus around the optic nerve using a slit lamp delivery system and a glass coverslip as a contact lens according to previously published procedures [28,29].”
MethodSelf-citationPrevention and Treatment of Age-Related Macular Degeneration: An Update for Pharmacists
Marshall, L. L., & Roach, J. (2013) · The Consultant Pharmacist · doi:10.4140/tcp.n.2013.723 · Cited by 19
Bhattarai, N., Piippo, N., Ranta‐aho, S., Mysore, Y., Kaarniranta, K., & Kauppinen, A. (2021) · Antioxidants · doi:10.3390/antiox10010067 · Cited by 18
Influence of triamcinolone intravitreal injection on retinochoroidal healing processes
Dot, C., Béhar‐Cohen, F., BenEzra, D., Doat, M., Jonet, L., May, F., & Jeanny, J. C. (2007) · Experimental Eye Research · doi:10.1016/j.exer.2007.01.024 · Cited by 15
Effect of Resveratrol-Based Nutritional Supplement on Choroidal Thickness: A Pilot Study
Wang, S., Moonasar, N., Xiao, X., Yin, T., Weinreb, R. N., & Sun, X. (2016) · Current Eye Research · doi:10.3109/02713683.2015.1119282 · Cited by 12 · cited 1×
“For example, a randomized clinical study showed that the RSV group (taking pills containing 100 mg of RSV) increased choroidal thickness (by EDI-OCT) one hour after RSV administration compared with baseline measurements [25].”
Method
Cited by
Oxidative Stress and Antioxidants in Age-Related Macular Degeneration
Kushwah, N. S., Bora, K., Maurya, M., Pavlovich, M. C., & Chen, J. (2023) · Antioxidants · doi:10.3390/antiox12071379 · Cited by 160
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“Nutritional anti-VEGF intervention against wet AMD has been shown to act by preventing MAPK activation in RPE cells [54], with the involvement of NFκB [55], and similar effects have been demonstrated in mouse models [56].”
BackgroundPinilla, I., Maneu, V., Campello, L., Fernández‐Sánchez, L., Martínez‐Gil, N., Kutsyr, O., Sánchez‐Sáez, X., Sánchez‐Castillo, C., Lax, P., & Cuenca, N. (2022) · Antioxidants · doi:10.3390/antiox11061086 · Cited by 53
Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
Yuan, Z., Yu, D., Gou, T., Tang, G., Guo, C., & Shi, J. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175931 · Cited by 33
Buonfiglio, F., Korb, C. A., Stoffelns, B. M., Pfeiffer, N., & Gericke, A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0124 · Cited by 54
“Courtaut and coworkers demonstrated in a murine model of CNV that a supplementation with Resvega®, a nutraceutical formulation of omega-3 fatty acids and RSV, significantly reduced CNV, highlighting an anti-angiogenetic effect of RSV [423].”
Metadata
- Authors
- Courtaut, F., Aires, V., Acar, N., Bretillon, L., Guerrera, I. C., Chhuon, C., Pais de Barros, J.-P., Olmiere, C., & Delmas, D.
- Affiliations
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Université de Bourgogne Franche-Comté, 21000 Dijon, France
- Proteomics Platform Necker, Université de Paris—Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, 75015 Paris, France
- Laboratoires Thea, 12 Rue Louis-Blériot, 63000 Clermont-Ferrand, France
- Corresponding author
- Delmas, Dominique
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-10-13
- Volume
- 22
- Issue
- 20
- Pages
- 11023
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8538314
- OpenAlex
- W3205588879
- Cited by
- 21
- References
- 33
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 3
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agence Nationale de la Recherche (ANR-11-LABX-0021)
- Association Nationale de la Recherche et de la Technologie
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- omega-3 fatty acids, resveratrol, nutraceutical supplementation, choroidal neovascularization, age-related macular degeneration, angiogenesis, laser-induced CNV, resveratrol metabolites, anti-VEGF therapy resistance, polyphenols
- MeSH terms
- Resveratrol, Animals, Disease Models, Animal, Female, Macular Degeneration, Fatty Acids, Omega-3, Dietary Supplements, Choroidal Neovascularization, Proteomics, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.